Cogent Biosciences (COGT) Operating Income (2017 - 2020)
Historic Operating Income for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to -$11.5 million.
- Cogent Biosciences' Operating Income fell 61142.86% to -$11.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$82.2 million, marking a year-over-year decrease of 15545.09%. This contributed to the annual value of -$333.4 million for FY2025, which is N/A changed from last year.
- As of Q4 2020, Cogent Biosciences' Operating Income stood at -$11.5 million, which was down 61142.86% from -$57.2 million recorded in Q3 2020.
- Cogent Biosciences' Operating Income's 5-year high stood at $2.2 million during Q4 2019, with a 5-year trough of -$57.2 million in Q3 2020.
- Moreover, its 4-year median value for Operating Income was -$8.2 million (2018), whereas its average is -$11.0 million.
- In the last 5 years, Cogent Biosciences' Operating Income surged by 12487.78% in 2019 and then plummeted by 61142.86% in 2020.
- Quarter analysis of 4 years shows Cogent Biosciences' Operating Income stood at -$6.9 million in 2017, then tumbled by 30.87% to -$9.0 million in 2018, then skyrocketed by 124.88% to $2.2 million in 2019, then crashed by 611.43% to -$11.5 million in 2020.
- Its Operating Income was -$11.5 million in Q4 2020, compared to -$57.2 million in Q3 2020 and -$7.4 million in Q2 2020.